Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT01881230 - tnAcity - 1L - Gemcitabine + Nab-paclitaxel / Protein-bound paclitaxel vs Carboplatin + Nab-paclitaxel / Protein-bound paclitaxel vs Carboplatin + Gemcitabine & Breast Cancer / Mammacarcinoma (TNBC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

First-line nab-P/C was active in mTNBC and resulted in a significantly longer PFS and improved risk/benefit profile vs nab-P/G or G/C
Yardley et al. 2018 Ann Oncol 29(8): 1763-1770
…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

NCT01881230 - tnAcity - 1L - Gemcitabine + Nab-paclitaxel / Protein-bound paclitaxel vs Carboplatin + Nab-paclitaxel / Protein-bound paclitaxel vs Carboplatin + Gemcitabine & Breast Cancer / Mammacarcinoma (TNBC)

Welcome to meRfi Microbiome!

Navigation

Contents

AI Chat

Links